{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T21:55:41Z","timestamp":1790286941811,"version":"4.1.0"},"reference-count":97,"publisher":"MDPI AG","issue":"17","license":[{"start":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T00:00:00Z","timestamp":1757030400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Immune dysregulation is being increasingly recognized as a leading sign of a wide spectrum of inborn errors of immunity (IEIs). Therefore, patients with IEIs are frequently managed in non-immunological settings, including hematology and oncology units, during the diagnostic process or follow-up. The most relevant hematological signs associated with IEIs comprise autoimmune cytopenia (AIC), lymphoproliferative diseases (LPD), malignancies, hemophagocytic lymphohystiocitosis (HLH), bone marrow failure (BMF), myelodysplastic syndromes (MDS), and peripheral or tissue eosinophilia. The prognosis of patients with IEIs can significantly improve when a molecular diagnosis is established, as it can allow the use of targeted treatments, guide appropriate follow-up strategies and, in some cases, support the rationale for hematopoietic stem cell transplantation or gene therapy. Therefore, there is an urgent need to recognize the warning signs suggestive for an underlying IEI among patients presenting with common hematological features and to ensure an appropriate diagnostic approach. As a general rule, clinicians should always provide a clinical alert in the presence of two or more IEI-associated hematological signs, as well as a positive familial history for IEI or hematologic immune dysregulation, a personal history of severe infections, and other signs of immune dysregulation. Concerning AIC, an increased likelihood of IEI is characteristic of patients with treatment refractoriness, autoimmune hemolytic anemia, or multilineage cytopenia. In the case of LPD, the main elements of suspicion are represented by the chronic or recurrent disease course, the persistence of Epstein\u2013Barr Virus (EBV) infection, and the development of lymphoproliferation in atypical localizations. Among patients with malignancy, clinicians should investigate for IEI those with rare neoplasia, virus-associated tumors, and an association with syndromic features, while patients with HLH should always receive an immunological assessment when a clear rheumatologic trigger, underlying malignancy, or well-recognized cause is not evident. The case of MDS and BMF is complex, as new monogenic entities are continuously being described. However, it is pivotal to consider the presence of monocytopenia, warts, vasculitis, and neurological disease, as well as specific cytogenetic abnormalities, such as chromosome 7 monosomy, as warning sings for IEIs. Finally, the main red flags for IEIs in patients with eosinophilia are skeletal\/facial abnormalities, recurrent abscesses, refractory eczema, organomegaly, or thrombocytopenia.<\/jats:p>","DOI":"10.3390\/jcm14176295","type":"journal-article","created":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T14:53:01Z","timestamp":1757083981000},"page":"6295","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Inborn Errors of Immunity in Pediatric Hematology and Oncology: Diagnostic Principles for Clinical Practice"],"prefix":"10.3390","volume":"14","author":[{"given":"Giulia","family":"Roberti","sequence":"first","affiliation":[{"name":"Section of Pediatric Hematology and Oncology, Azienda Ospedaliero-Universitaria Pisana, 56126 Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Maestrini","sequence":"additional","affiliation":[{"name":"Section of Pediatric Hematology and Oncology, Azienda Ospedaliero-Universitaria Pisana, 56126 Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrice","family":"Polito","sequence":"additional","affiliation":[{"name":"Section of Pediatric Hematology and Oncology, Azienda Ospedaliero-Universitaria Pisana, 56126 Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"Amato","sequence":"additional","affiliation":[{"name":"Section of Pediatric Hematology and Oncology, Azienda Ospedaliero-Universitaria Pisana, 56126 Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Parolo","sequence":"additional","affiliation":[{"name":"Section of Pediatric Hematology and Oncology, Azienda Ospedaliero-Universitaria Pisana, 56126 Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"Casazza","sequence":"additional","affiliation":[{"name":"Section of Pediatric Hematology and Oncology, Azienda Ospedaliero-Universitaria Pisana, 56126 Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5968-1945","authenticated-orcid":false,"given":"Rita","family":"Consolini","sequence":"additional","affiliation":[{"name":"Section of Clinical and Laboratory Immunology, University of Pisa, 56126 Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4160-3727","authenticated-orcid":false,"given":"Giorgio","family":"Costagliola","sequence":"additional","affiliation":[{"name":"Section of Pediatric Hematology and Oncology, Azienda Ospedaliero-Universitaria Pisana, 56126 Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,9,5]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/j.jaci.2021.04.015","article-title":"Initial presenting manifestations in 16,486 patients with inborn errors of immunity include infections and noninfectious manifestations","volume":"148","author":"Thalhammer","year":"2021","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Cortesi, M., Dotta, L., Cattalini, M., Lougaris, V., Soresina, A., and Badolato, R. (2024). Unmasking inborn errors of immunity: Identifying the red flags of immune dysregulation. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1497921"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Costagliola, G., Peroni, D., and Consolini, R. (2022). Beyond Infections: New Warning Signs for Inborn Errors of Immunity in Children. Front. Pediatr., 10.","DOI":"10.3389\/fped.2022.855445"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"109302","DOI":"10.1016\/j.clim.2023.109302","article-title":"Immune tolerance breakdown in inborn errors of immunity: Paving the way to novel therapeutic approaches","volume":"251","author":"Giardino","year":"2023","journal-title":"Clin. Immunol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"eabb1662","DOI":"10.1126\/sciimmunol.abb1662","article-title":"Human inborn errors of immunity: An expanding universe","volume":"5","author":"Notarangelo","year":"2020","journal-title":"Sci. Immunol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1111\/bcp.14509","article-title":"Targeted pharmacologic immunomodulation for inborn errors of immunity","volume":"88","author":"Sacco","year":"2022","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jaut.2019.01.011","article-title":"Primary immunodeficiency and autoimmunity: A comprehensive review","volume":"99","author":"Rojas","year":"2019","journal-title":"J. Autoimmun."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.jaci.2016.12.978","article-title":"Autoimmune and inflammatory manifestations occur frequently in patients with primary immunodeficiencies","volume":"140","author":"Fischer","year":"2017","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Miano, M., Guardo, D., Grossi, A., Palmisani, E., Fioredda, F., Terranova, P., Cappelli, E., Lupia, M., Traverso, M., and Dell\u2019Orso, G. (2022). Underlying Inborn Errors of Immunity in Patients with Evans Syndrome and Multilineage Cytopenias: A Single-Centre Analysis. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.869033"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"e114","DOI":"10.1016\/S2352-3026(23)00362-9","article-title":"Diagnostic evaluation of paediatric autoimmune lymphoproliferative immunodeficiencies (ALPID): A prospective cohort study","volume":"11","author":"Staus","year":"2024","journal-title":"Lancet Haematol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1002\/ajh.27221","article-title":"Late-onset and long-lasting neutropenias in the young: A new entity anticipating immune-dysregulation disorders","volume":"99","author":"Fioredda","year":"2024","journal-title":"Am. J. Hematol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1182\/blood-2014-06-583260","article-title":"Autoimmune and other cytopenias in primary immunodeficiencies: Pathomechanisms, novel differential diagnoses, and treatment","volume":"124","author":"Seidel","year":"2014","journal-title":"Blood"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1159\/000535258","article-title":"Autoimmune Cytopenias Are Highly Associated with Inborn Errors of Immunity and They May Be the Initial Presentations in Cases without Severe Infections","volume":"185","author":"Taskin","year":"2024","journal-title":"Int. Arch. Allergy Immunol."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Schiavo, E., Martini, B., Attardi, E., Consonni, F., Ciullini Mannurita, S., Coniglio, M.L., Tellini, M., Chiocca, E., Fotzi, I., and Luti, L. (2022). Autoimmune Cytopenias and Dysregulated Immunophenotype Act as Warning Signs of Inborn Errors of Immunity: Results from a Prospective Study. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.790455"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1182\/hematology.2020000173","article-title":"How to Evaluate for Immunodeficiency in Patients with Autoimmune Cytopenias: Laboratory Evaluation for the Diagnosis of Inborn Errors of Immunity","volume":"2020","author":"Abraham","year":"2020","journal-title":"Hematol. Am. Soc. Hematol. Educ. Program"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3389\/fped.2017.00179","article-title":"The Centenary of Immune Thrombocytopenia-Part 2: Revising Diagnostic and Therapeutic Approach","volume":"5","author":"Consolini","year":"2017","journal-title":"Front. Pediatr."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Sharma, S., Pilania, R.K., Anjani, G., Sudhakar, M., Arora, K., Tyagi, R., Dhaliwal, M., Vignesh, P., Rawat, A., and Singh, S. (2022). Lymphoproliferation in Inborn Errors of Immunity: The Eye Does Not See What the Mind Does Not Know. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.856601"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/cei.13620","article-title":"Lymphadenopathy at the crossroad between immunodeficiency and autoinflammation: An intriguing challenge","volume":"205","author":"Costagliola","year":"2021","journal-title":"Clin. Exp. Immunol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"14","DOI":"10.18176\/jiaci.0388","article-title":"Common Variable Immunodeficiency: Epidemiology, Pathogenesis, Clinical Manifestations, Diagnosis, Classification, and Management","volume":"30","author":"Yazdani","year":"2020","journal-title":"J. Investig. Allergol. Clin. Immunol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.anai.2021.03.005","article-title":"State-of-the-art diagnostic evaluation of common variable immunodeficiency","volume":"127","author":"Lee","year":"2021","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1046\/j.1365-2249.2003.02253.x","article-title":"Lymphoproliferative disease in antibody deficiency: A multi-centre study","volume":"134","author":"Gompels","year":"2003","journal-title":"Clin. Exp. Immunol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/j.jaci.2011.12.647","article-title":"Common variable immunodeficiency","volume":"129","author":"Maglione","year":"2012","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1007\/s10875-020-00769-8","article-title":"Lymphoproliferative Disease in CVID: A Report of Types and Frequencies from a US Patient Registry","volume":"40","author":"Yakaboski","year":"2020","journal-title":"J. Clin. Immunol."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Ho, H., and Cunningham-Rundles, C. (2020). Non-infectious Complications of Common Variable Immunodeficiency: Updated Clinical Spectrum, Sequelae, and Insights to Pathogenesis. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.00149"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s11882-016-0597-6","article-title":"Autoimmune and Lymphoproliferative Complications of Common Variable Immunodeficiency","volume":"16","author":"Maglione","year":"2016","journal-title":"Curr. Allergy Asthma Rep."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.1007\/s00277-025-06456-1","article-title":"Inborn errors of immunity presenting with lymphoproliferation: Lessons from a case series","volume":"104","author":"Costagliola","year":"2025","journal-title":"Ann. Hematol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s10875-014-0052-1","article-title":"Ill-defined germinal centers and severely reduced plasma cells are histological hallmarks of lymphadenopathy in patients with common variable immunodeficiency","volume":"34","author":"Unger","year":"2014","journal-title":"J. Clin. Immunol."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"van Stigt, A.C., Dik, W.A., Kamphuis, L.S.J., Smits, B.M., van Montfrans, J.M., van Hagen, P.M., Dalm, V.A.S.H., and Ijspeert, H. (2020). What Works When Treating Granulomatous Disease in Genetically Undefined CVID? A Systematic Review. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.606389"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1182\/blood-2010-04-280347","article-title":"Revised diagnostic criteria and classification for the autoimmune lymphoproliferative syndrome (ALPS): Report from the 2009 NIH International Workshop","volume":"116","author":"Oliveira","year":"2010","journal-title":"Blood"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s40348-023-00167-1","article-title":"Autoimmune lymphoproliferative immunodeficiencies (ALPID) in childhood: Breakdown of immune homeostasis and immune dysregulation","volume":"10","author":"Toskov","year":"2023","journal-title":"Mol. Cell. Pediatr."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jaci.2023.11.004","article-title":"Autoimmune lymphoproliferative immunodeficiencies (ALPIDs): A proposed approach to redefining ALPS and other lymphoproliferative immune disorders","volume":"153","author":"Magerus","year":"2024","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1182\/blood.2019002072","article-title":"Increased activation of PI3 kinase-\u03b4 predisposes to B-cell lymphoma","volume":"135","author":"Durandy","year":"2020","journal-title":"Blood"},{"key":"ref_33","unstructured":"Adam, M.P., Feldman, J., Mirzaa, G.M., Pagon, R.A., Wallace, S.E., and Amemiya, A. (2025). Activated PI3K Delta Syndrome. GeneReviews\u00ae [Internet], University of Washington."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s10875-024-01835-1","article-title":"Report of the Italian Cohort with Activated Phosphoinositide 3-Kinase \u03b4 Syndrome in the Target Therapy Era","volume":"45","author":"Barzaghi","year":"2024","journal-title":"J. Clin. Immunol."},{"key":"ref_35","first-page":"241","article-title":"Primary Immunodeficiencies Associated with EBV Disease","volume":"390","author":"Cohen","year":"2015","journal-title":"Curr. Top Microbiol. Immunol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1080\/1744666X.2022.2074400","article-title":"Diagnosis and clinical management of Wiskott-Aldrich syndrome: Current and emerging techniques","volume":"18","author":"Cavannaugh","year":"2022","journal-title":"Expert Rev. Clin. Immunol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1182\/blood-2014-11-567917","article-title":"JMML and RALD (Ras-associated autoimmune leukoproliferative disorder): Common genetic etiology yet clinically distinct entities","volume":"125","author":"Calvo","year":"2015","journal-title":"Blood"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Pilania, R.K., Banday, A.Z., Sharma, S., Kumrah, R., Joshi, V., Loganathan, S., Dhaliwal, M., Jindal, A.K., Vignesh, P., and Suri, D. (2022). Deficiency of Human Adenosine Deaminase Type 2\u2014A Diagnostic Conundrum for the Hematologist. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.869570"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"e26912","DOI":"10.1002\/pbc.26912","article-title":"Deficiency of ADA2 mimicking autoimmune lymphoproliferative syndrome in the absence of livedo reticularis and vasculitis","volume":"65","author":"Alsultan","year":"2018","journal-title":"Pediatr. Blood Cancer"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s13223-022-00747-2","article-title":"Diversity of malignancies in patients with different types of inborn errors of immunity","volume":"18","author":"Tavakol","year":"2022","journal-title":"Allergy Asthma Clin. Immunol."},{"key":"ref_41","first-page":"14","article-title":"Inborn errors of immunity and malignancy","volume":"37","author":"Sipambo","year":"2024","journal-title":"Curr. Allergy Clin. Immunol."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Mortaz, E., Tabarsi, P., Mansouri, D., Khosravi, A., Garssen, J., Velayati, A., and Adcock, I.M. (2016). Cancers Related to Immunodeficiencies: Update and Perspectives. Front. Immunol., 7.","DOI":"10.3389\/fimmu.2016.00365"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"245","DOI":"10.2174\/1573396315666190917154058","article-title":"Primary Immunodeficiency and Cancer in Children. A Review of the Literature","volume":"15","author":"Kebudi","year":"2019","journal-title":"Curr. Pediatr. Rev."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s10875-024-01810-w","article-title":"Cancer Trends in Inborn Errors of Immunity: A Systematic Review and Meta-Analysis","volume":"45","author":"Fekrvand","year":"2024","journal-title":"J. Clin. Immunol."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Riaz, I., Faridi, W., Patnaik, M., and Abraham, R. (2019). A systematic review on predisposition to lymphoid (B and T cell) neoplasias in patients with primary immunodeficiencies and immune dysregulatory disorders (inborn errors of immunity). Front. Immunol., 10.","DOI":"10.3389\/fimmu.2019.00777"},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Tiri, A., Masetti, R., Conti, F., Tignanelli, A., Turrini, E., Bertolini, P., Esposito, S., and Pession, A. (2021). Inborn Errors of Immunity and Cancer. Biology, 10.","DOI":"10.3390\/biology10040313"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1080\/08880018.2022.2085830","article-title":"How to recognize inborn errors of immunity in a child presenting with a malignancy: Guidelines for the pediatric hemato-oncologist","volume":"40","author":"Bosch","year":"2023","journal-title":"Pediatr. Hematol. Oncol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1182\/blood-2016-10-743302","article-title":"Gain-of-function SAMD9L mutations cause a syndrome of cytopenia, immunodeficiency, MDS, and neurological symptoms","volume":"129","author":"Tesi","year":"2017","journal-title":"Blood"},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Bomken, S., van der Werff Ten Bosch, J., Attarbaschi, A., Bacon, C.M., Borkhardt, A., Boztug, K., Fischer, U., Hauck, F., Kuiper, R.P., and Lammens, T. (2018). Current understanding and future research priorities in malignancy associated with inborn errors of immunity and DNA repair disorders: The perspective of an interdisciplinary working group. Front. Immunol., 9.","DOI":"10.3389\/fimmu.2018.02912"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1007\/s10875-015-0186-9","article-title":"Nijmegen breakage syndrome: Clinical and immunological features, long-term outcome and treatment options\u2014A retrospective analysis","volume":"35","author":"Gregorek","year":"2015","journal-title":"J. Clin. Immunol."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Koldej, R.M., Prabahran, A., Tan, C.W., Ludford-Menting, M., Morgan, H., Holzwart, N., Davis, M.J., and Ritchie, D.S. (2023). Spatial proteomics identifies a spectrum of immune dysregulation in acquired bone marrow failure syndromes. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1213560"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"e20250002","DOI":"10.70962\/jhi.20250002","article-title":"The 2024 update of IUIS phenotypic classification of human inborn errors of immunity","volume":"1","author":"Bousfiha","year":"2025","journal-title":"J. Hum. Immun."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"101197","DOI":"10.1016\/j.beha.2020.101197","article-title":"Germline predisposition in myeloid neoplasms: Unique genetic and clinical features of GATA2 deficiency and SAMD9\/SAMD9L syndromes","volume":"33","author":"Sahoo","year":"2020","journal-title":"Best Pract. Res. Clin. Haematol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1146\/annurev-pathmechdis-111523-023420","article-title":"Inherited Predispositions to Myeloid Neoplasms: Pathogenesis and Clinical Implications","volume":"20","author":"Liu","year":"2025","journal-title":"Annu. Rev. Pathol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1182\/blood-2017-09-806489","article-title":"A landscape of germ line mutations in a cohort of inherited bone marrow failure patients","volume":"131","author":"Bluteau","year":"2018","journal-title":"Blood"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1182\/blood.2022017764","article-title":"The spectrum of GATA2 deficiency syndrome","volume":"141","author":"Calvo","year":"2023","journal-title":"Blood"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1097\/ACI.0000000000000126","article-title":"GATA2 deficiency","volume":"15","author":"Hsu","year":"2015","journal-title":"Curr. Opin. Allergy Clin. Immunol."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Rukerd, M.R.Z., Mirkamali, H., Nakhaie, M., and Alizadeh, S.D. (2024). GATA2 deficiency and hemophagocytic lymphohistiocytosis (HLH): A systematic review of reported cases. BMC Infect. Dis., 24.","DOI":"10.1186\/s12879-024-10145-1"},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Santiago, M., Liquori, A., Such, E., Z\u00fa\u00f1iga, \u00c1., and Cervera, J. (2023). The Clinical Spectrum, Diagnosis, and Management of GATA2 Deficiency. Cancers, 15.","DOI":"10.3390\/cancers15051590"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1038\/s41591-021-01511-6","article-title":"Clinical evolution, genetic landscape and trajectories of clonal hematopoiesis in SAMD9\/SAMD9L syndromes","volume":"27","author":"Sahoo","year":"2021","journal-title":"Nat. Med."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Suntharalingham, J.P., Ishida, M., Del Valle, I., Stalman, S.E., Solanky, N., Wakeling, E., Moore, G.E., Achermann, J.C., and Buonocore, F. (2022). Emerging phenotypes linked to variants in SAMD9 and MIRAGE syndrome. Front. Endocrinol., 13.","DOI":"10.3389\/fendo.2022.953707"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1111\/bjh.17006","article-title":"Prevalence of germline GATA2 and SAMD9\/9L variants in paediatric haematological disorders with monosomy 7","volume":"191","author":"Yoshida","year":"2020","journal-title":"Br. J. Haematol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s10875-018-0525-8","article-title":"Deficiency of Adenosine Deaminase 2 (DADA2): Updates on the Phenotype, Genetics, Pathogenesis, and Treatment","volume":"38","author":"Meyts","year":"2018","journal-title":"J. Clin. Immunol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1001\/jamanetworkopen.2023.15894","article-title":"Evaluation and Management of Deficiency of Adenosine Deaminase 2: An International Consensus Statement","volume":"6","author":"Lee","year":"2023","journal-title":"JAMA Netw. Open"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/nrrheum.2015.179","article-title":"Macrophage activation syndrome in the era of biologic therapy","volume":"12","author":"Grom","year":"2016","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1182\/blood.2019000936","article-title":"Pediatric hemophagocytic lymphohistiocytosis","volume":"135","author":"Canna","year":"2020","journal-title":"Blood"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"e15516","DOI":"10.1111\/ped.15516","article-title":"Rare diseases presenting with hemophagocytic lymphohistiocytosis","volume":"65","author":"Kanegane","year":"2023","journal-title":"Pediatr. Int."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"423","DOI":"10.3892\/etm.2023.12122","article-title":"Secondary hemophagocytic lymphohistiocytosis in children","volume":"26","author":"Benevenuta","year":"2023","journal-title":"Exp. Ther. Med."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1186\/s13023-025-03698-0","article-title":"Perspectives on the current diagnostic and treatment paradigms in secondary hemophagocytic lymphohistiocytosis (HLH)","volume":"20","author":"Naymagon","year":"2025","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/imr.12791","article-title":"Signaling pathways involved in the T-cell-mediated immunity against Epstein-Barr virus: Lessons from genetic diseases","volume":"291","author":"Latour","year":"2019","journal-title":"Immunol. Rev."},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Boyarchuk, O., Volokha, A., Yarema, N., Dyvoniak, O., Tomashivska, T., Shymanska, I., Makukh, H., and Walter, J.E. (2025). Fatal HLH in patients with X-linked lymphoproliferative disease 1 due to a novel variant in SH2D1A: Case report. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1602107"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1182\/blood-2010-07-298372","article-title":"Clinical similarities and differences of patients with X-linked lymphoproliferative syndrome type 1 (XLP-1\/SAP deficiency) versus type 2 (XLP-2\/XIAP deficiency)","volume":"117","author":"Canioni","year":"2011","journal-title":"Blood"},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Ricci, S., Sarli, W.M., Lodi, L., Canessa, C., Lippi, F., Dini, D., Ferrari, M., Pisano, L., Sieni, E., and Indolfi, G. (2024). HLH as an additional warning sign of inborn errors of immunity beyond familial-HLH in children: A systematic review. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1282804"},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Wegehaupt, O., Wustrau, K., Lehmberg, K., and Ehl, S. (2020). Cell Versus Cytokine\u2014Directed Therapies for Hemophagocytic Lymphohistiocytosis (HLH) in Inborn Errors of Immunity. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.00808"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"e27929","DOI":"10.1002\/pbc.27929","article-title":"Challenges in the diagnosis of hemophagocytic lymphohistiocytosis: Recommendations from the Norh American Consortium for Histiocytosis (NACHO)","volume":"66","author":"Jordan","year":"2019","journal-title":"Pediatr. Blood Cancer"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1097\/ACI.0000000000001078","article-title":"Hypereosinophilia: Clinical and therapeutic approach in 2025","volume":"25","author":"Taurisano","year":"2025","journal-title":"Curr. Opin. Allergy Clin. Immunol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"100513","DOI":"10.1016\/j.waojou.2021.100513","article-title":"Inborn errors of immunity with atopic phenotypes: A practical guide for allergists","volume":"14","author":"Castagnoli","year":"2021","journal-title":"World Allergy Organ. J."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/pai.13633","article-title":"Primary atopic disorders and chronic skin disease","volume":"33","author":"Cinicola","year":"2022","journal-title":"Pediatr. Allergy Immunol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.iac.2015.05.004","article-title":"Eosinophilia Associated with Disorders of Immune Deficiency or Immune Dysregulation","volume":"35","author":"Williams","year":"2015","journal-title":"Immunol. Allergy Clin. N. Am."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/ACI.0000000000001059","article-title":"Inborn errors of immunity with atopic phenotypes in the allergy and immunology clinic: A practical review","volume":"25","author":"Taietti","year":"2025","journal-title":"Curr. Opin. Allergy Clin. Immunol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s11882-025-01196-8","article-title":"Hyper IgE Syndrome: Bridging the Gap Between Immunodeficiency, Atopy, and Allergic Diseases","volume":"25","author":"Sutanto","year":"2025","journal-title":"Curr. Allergy Asthma Rep."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1007\/s10875-021-01051-1","article-title":"STAT3 Hyper-IgE Syndrome-an Update and Unanswered Questions","volume":"41","author":"Tsilifis","year":"2021","journal-title":"J. Clin. Immunol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.jaci.2009.10.059","article-title":"Mutations in STAT3 and diagnostic guidelines for hyper-IgE syndrome","volume":"125","author":"Woellner","year":"2010","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1016\/j.jaci.2018.10.026","article-title":"Tregopathies: Monogenic diseases resulting in regulatory T-cell deficiency","volume":"142","author":"Cepika","year":"2018","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1097\/ACI.0000000000001033","article-title":"Expanding the spectrum of IPEX: From new clinical findings to novel treatments","volume":"24","author":"Voarino","year":"2024","journal-title":"Curr. Opin. Allergy Clin. Immunol."},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Gambineri, E., Ciullini Mannurita, S., Hagin, D., Vignoli, M., Anover-Sombke, S., DeBoer, S., Segundo, G.R.S., Allenspach, E.J., Favre, C., and Ochs, H.D. (2018). Clinical, Immunological, and Molecular Heterogeneity of 173 Patients with the Phenotype of Immune Dysregulation, Polyendocrinopathy, Enteropathy, X-Linked (IPEX) Syndrome. Front. Immunol., 9.","DOI":"10.3389\/fimmu.2018.02411"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s10875-024-01772-z","article-title":"Genetic Testing in Patients with Autoimmune Lymphoproliferative Syndrome: Experience of 802 Patients at Cincinnati Children\u2019s Hospital Medical Center","volume":"44","author":"Xu","year":"2024","journal-title":"J. Clin. Immunol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1002\/ajh.27183","article-title":"Wiskott-Aldrich syndrome","volume":"99","author":"Pelling","year":"2024","journal-title":"Am. J. Hematol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.jaci.2013.09.044","article-title":"Establishing diagnostic criteria for severe combined immunodeficiency disease (SCID), leaky SCID, and Omenn syndrome: The Primary Immune Deficiency Treatment Consortium experience","volume":"133","author":"Shearer","year":"2014","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1016\/j.jaip.2019.03.014","article-title":"Immunophenotype Anomalies Predict the Development of Autoimmune Cytopenia in 22q11.2 Deletion Syndrome","volume":"7","author":"Montin","year":"2019","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.jaci.2023.12.022","article-title":"Multilayer concept of autoimmune mechanisms and manifestations in inborn errors of immunity: Relevance for precision therapy","volume":"153","author":"Seidel","year":"2024","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Slatter, M., and Lum, S. (2023). Personalized hematopoietic stem cell transplantation for inborn errors of immunity. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1162605"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"261","DOI":"10.2147\/TCRM.S462996","article-title":"The Etiologic Landscape of Lymphoproliferation in Childhood: Proposal for a Diagnostic Approach Exploring from Infections to Inborn Errors of Immunity and Metabolic Diseases","volume":"20","author":"Costagliola","year":"2024","journal-title":"Ther. Clin. Risk Manag."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1182\/blood.2024025077","article-title":"Diagnostic guidelines for familial hemophagocytic lymphohistiocytosis revisited","volume":"144","author":"Henter","year":"2024","journal-title":"Blood"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.cmi.2022.10.003","article-title":"When to suspect inborn errors of immunity in Epstein-Barr virus-related lymphoproliferative disorders","volume":"29","author":"Sacco","year":"2023","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1182\/blood.2020006481","article-title":"Inherited bone marrow failure in the pediatric patient","volume":"140","author":"Dokal","year":"2022","journal-title":"Blood"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1002\/ajh.26242","article-title":"Genetic screening of children with marrow failure. The role of primary Immunodeficiencies","volume":"96","author":"Miano","year":"2021","journal-title":"Am. J. Hematol."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/17\/6295\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:41:03Z","timestamp":1760035263000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/17\/6295"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,5]]},"references-count":97,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2025,9]]}},"alternative-id":["jcm14176295"],"URL":"https:\/\/doi.org\/10.3390\/jcm14176295","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,5]]}}}